There’s finally some good news for those who’d like to try humantherapy with induced pluripotent stem cells, adult cellsreprogrammed to act like embryonic stem cells. According to recent studies, IPS ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its ...
ATLANTA--(BUSINESS WIRE)--NSS Labs has confirmed that the Stonesoft IPS-1302 demonstrates 100 percent protection against all tested evasion techniques and low total cost of ownership (TCO) during real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback